pAAV-CMV-NLS-AcrIIA4 Citations (2)

Originally described in: Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.
Bubeck F, Hoffmann MD, Harteveld Z, Aschenbrenner S, Bietz A, Waldhauer MC, Borner K, Fakhiri J, Schmelas C, Dietz L, Grimm D, Correia BE, Eils R, Niopek D Nat Methods. 2018 Oct 30. pii: 10.1038/s41592-018-0178-9. doi: 10.1038/s41592-018-0178-9. PubMed Journal

---

Articles Citing pAAV-CMV-NLS-AcrIIA4

Articles
Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome. Forsberg KJ, Bhatt IV, Schmidtke DT, Javanmardi K, Dillard KE, Stoddard BL, Finkelstein IJ, Kaiser BK, Malik HS. Elife. 2019 Sep 10;8. pii: 46540. doi: 10.7554/eLife.46540. PubMed
Mechanism of Cas9 inhibition by AcrIIA11. Dillard KE, Zhang H, Dubbs LZ, Chou CW, Terrace C, Javanmardi K, Kim W, Forsberg KJ, Finkelstein IJ. Nucleic Acids Res. 2025 Apr 22;53(8):gkaf318. doi: 10.1093/nar/gkaf318. PubMed

If you have published an article using this material, please email us at to have your article added to this page.